High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study
Julian Panés 1
Jean-Frederic Colombel 2
Geert R. D'Haens 3
Stefan Schreiber 4
Remo Panaccione 5
Laurent Peyrin-Biroulet 6
Edward Loftus, Jr
Silvio Danese
Edouard Louis
Alessandro Armuzzi
Marc Ferrante
Harald Vogelsang
Jessica Lefebvre
Thao Doan
Nisha V. Kwatra
Nael M. Mostafa
Wangang Xie
Bidan Huang
Joel Petersson;;
1 Hospital Clinic de Barcelona,Barcelona,Spain
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator,Amsterdam,Netherlands
4 University Hospital Schleswig-Holstein,Kiel,Germany
5 University of Calgary,Calgary,Canada
6 Nancy Unive
Session
Paradigm shifts in IBD treatment
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu